SCHEMBL17429702

SCHEMBL17429702

COC(=O)c1ccc(CCCc2cccc(C)n2)c(B2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR2 P25025 3/20 0.35
▸ UCHL1 P09936 1/20 0.34
▸ CYP4F2 P78329 2/20 0.34
▸ CYP4A11 Q02928 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ OPRM1 P35372 1/20 0.34
▸ OPRD1 P41143 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ NQO2 P16083 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LIPE Q05469 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ HSD17B3 P37058 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ ALOX5 P09917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17400118 0.89 LIPG (0.37) CXCR2UCHL1CYP4F2CYP4A11NQO2
SCHEMBL17429704 0.83 UCHL1 (0.33) CXCR2UCHL1MEN1KMT2AALDH1A1
SCHEMBL17429646 0.82 CYP4A11 (0.45) CYP4F2CYP4A11MEN1KMT2ANQO2
SCHEMBL17429651 0.81 CYP4A11 (0.38) CXCR2UCHL1CYP4F2CYP4A11MEN1
SCHEMBL17386132 0.79 MTNR1A (0.45) CYP4F2CYP4A11MEN1KMT2ARAB9A
SCHEMBL17429703 0.79 P4HB (0.45) CYP4F2CYP4A11MEN1OPRM1OPRD1
SCHEMBL17400105 0.79 ALDH1A1 (0.43) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL17429645 0.78 TDP1 (0.35) CXCR2UCHL1ALDH1A1NPC1RAB9A
SCHEMBL18362455 0.78 CXCR2 (0.39) CXCR2UCHL1CYP4F2CYP4A11KMT2A
SCHEMBL17429652 0.77 UCHL1 (0.33) CXCR2UCHL1CYP4A11NQO2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 CXCR2 461/4885UCHL1 4494/4885CYP4F2 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback